---
document_datetime: 2024-07-04 11:49:45
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/grasustek-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: grasustek-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 2.8866955
conversion_datetime: 2025-12-27 22:37:08.002867
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Grasustek

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                       | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IA/0017              | B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation | 13/06/2024                          | n/a                                         |                                  |           |
| IB/0016              | B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation                                | 22/05/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| R/0014    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                             | 22/02/2024   | 17/05/2024   | SmPC and PL   | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Grasustek in the approved indication remains favourable and therefore recommended the renewal of the marketing   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0015   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                        | 24/04/2024   | n/a          |               |                                                                                                                                                                                                                                    |
| IA/0013/G | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 07/07/2023   | n/a          |               |                                                                                                                                                                                                                                    |
| IB/0012/G | This was an application for a group of variations. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation                                                         | 05/07/2023   | n/a          |               |                                                                                                                                                                                                                                    |
| N/0011    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                    | 17/03/2023   | 17/05/2024   | PL            |                                                                                                                                                                                                                                    |
| IB/0008/G | This was an application for a group of variations.                                                                                                                                                                                                                                                  | 24/02/2023   | n/a          |               |                                                                                                                                                                                                                                    |

<div style=\"page-break-after: always\"></div>

|                    | B.I.z - Quality change - Active substance - Other variation B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test                                                                                                           |            |            |    |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|-----------------------------------|
| IB/0010/G          | This was an application for a group of variations. B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation                                                                          | 10/02/2023 | n/a        |    |                                   |
| IA/0007            | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                    | 22/11/2022 | n/a        |    |                                   |
| PSUSA/2326/ 202201 | Periodic Safety Update EU Single assessment - pegfilgrastim                                                                                                                                                                                                                                                     | 29/09/2022 | n/a        |    | PRAC Recommendation - maintenance |
| N/0006             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                | 10/08/2022 | 17/05/2024 | PL |                                   |
| IB/0004/G          | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB | 02/12/2021 | n/a        |    |                                   |

<div style=\"page-break-after: always\"></div>

|           | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                                                                                                                                                                                                         |            |            |                                  |         |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------|
| IB/0003/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by | 25/06/2021 | 08/07/2022 | SmPC, Labelling and PL           | the MAH |
| IB/0002   | B.I.d.1.z - Stability of AS - Change in the re-test period/storage period or storage conditions - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 18/05/2020 | n/a        |                                  |         |
| IB/0001   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                         | 05/03/2020 | 26/03/2021 | SmPC, Annex II, Labelling and PL |         |